Life-threatening idiopathic reaction to hydrochlorothiazide treated with veno-venous extracorporeal membrane oxygenation

Perfusion. 2018 May;33(4):320-322. doi: 10.1177/0267659117745370. Epub 2017 Nov 27.

Abstract

Hydrochlorothiazide has been shown to cause rare, but serious non-cardiogenic pulmonary edema. We present a case report of a patient with apparent septic shock and acute respiratory distress syndrome (ARDS) requiring life-sustaining veno-venous extracorporeal membrane oxygenation (VV-ECMO). Upon further review of the literature and the chronology of the patient's presentation, her condition was most likely due to an immune-mediated reaction to hydrochlorothiazide. This represents the first case, to our knowledge, of such a severe reaction to hydrochlorothiazide supported with ECMO therapy.

Keywords: adverse drug reaction; extracorporeal membrane oxygenation; hydrochlorothiazide; pulmonary edema; shock.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Diuretics / adverse effects*
  • Extracorporeal Membrane Oxygenation* / methods
  • Female
  • Humans
  • Hydrochlorothiazide / adverse effects*
  • Respiratory Distress Syndrome / complications
  • Respiratory Distress Syndrome / therapy*

Substances

  • Diuretics
  • Hydrochlorothiazide